Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin

Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin

PharmaMar

10 months
62 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD discusses the recent data released and advantages and potential limitations of the new drug.
Up Next Autoplay